No profile data available.
Pathkey.AI Ltd (PKY.AX) is a healthcare company in the medical sector application systems industry, based in Sydney, Australia.
It reported revenue of 397,637 AUD for fiscal year 2024, down 35.2% from fiscal year 2023, and net income of -3.13 million AUD. Its market capitalization was 28.38 million AUD as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2024; market data as of October 9, 2026.
AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. AI Ltd in August 2025. AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Pathkey.AI reported 397,637 AUD in revenue for fiscal year 2024, down 35.2% from 613,607 AUD in fiscal year 2023.
28.38 million AUD as of October 9, 2026.
Listed companies of a similar size in the same industry (medical sector application systems) include Singular Health Group Ltd (SHG.AX), Mach7 Technologies Limited (M7T.AX), HeraMED Limited (HMD.AX), Vitasora Health Limited (VHL.AX).